It is becoming increasingly clear that tumour cells must be studied in the context of their 3D tissue microenvironment to obtain accurate information about their biology and identify relevant drug targets. Ridky et al. describe a new 3D in vitro model of invasive neoplasia that can be derived using the four stratified squamous epithelia that are associated with human cancer: epidermis, oropharynx, oesophagus and cervix. The authors transformed the epithelia by inducing tumour-associated signalling pathways and then cultured them with an intact basement membrane supported by cell-populated living stroma. This multi-tissue model recapitulated many features of in vivo tumour progression, including epithelial invasion of the basement membrane. Gene-expression profiling provided further support that the system faithfully models human epithelial cancer, and inhibitor studies indicate that it could be used to screen for new therapeutics, including those that target the tumour microenvironment.
Invasive human epithelial neoplasia in 3D Open Access
Invasive human epithelial neoplasia in 3D. Dis Model Mech 1 January 2011; 4 (1): 2. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
A new perspective on disease research
DMM publishes perspectives - peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Other journals from
The Company of Biologists